摘要
目的:研究急性肾损伤( AKI)患者与慢性肾脏病( CKD)合并AKI( AonC)患者的预后。方法入选北京友谊医院医疗保健中心2009年8月至2013年10月期间收治的AonC患者147例,男性105例,女性42例,年龄(83.95±7.04)岁;同期单纯AKI患者270例,男性226例,女性44例,年龄(81.75±6.98)岁,比较两组患者近期(1年内)预后。结果单纯AKI患者随访30 d时的病死率高于AonC患者,差异有统计学意义(P<0.05),随访90 d和1年时的病死率差异无统计学意义(P>0.05);两组存活患者的肾功能恢复率差异无统计学意义(P>0.05);不同估算肾小球滤过率(eGFR)水平的AonC患者随访30 d、90 d和1年病死率的差异无统计学意义(P>0.05)。 Cox多因素回归分析表明是否合并CKD与患者30 d病死率无关(P=0.068),与AKI分期、合并贫血、低蛋白血症、心力衰竭、恶性肿瘤和多器官功能障碍综合征(MODS)相关,肾脏替代治疗( RRT)为保护性因素。结论老年AKI患者患病率和病死率高,是否合并CKD与近期预后无明显相关。
Objective To analyze the prognosis of the elderly patients with acute kidney injury ( AKI) and those suffering from acute on chronic kidney injury.Methods A total of 147 patients (105 males and 42 females, at a mean age of 83.95 ±7.04) with acute on chronic AKI (AonC) and 270 cases (226 males and 44 females, at a mean age of 81.75 ±6.98) with denovo AKI admitted in our center from August 2009 to October 2013 were enrolled in this study.Their short-term outcomes (within 1 year) were analyzed. Results The 30-day mortality was significantly higher in the AKI than the AonC patients (P〈0.05), but there were no differences in that of 90-day and 1-year (P〉0.05).No difference was seen in the recovery of renal function between the survivals from the 2 group (P〉0.05).There were no differences in the 30-day,90-day,1-year mortalities among the AonC patients with different estimated glomerular filtration rates ( eGFR) .COX multivariate regression analysis showed that complication with chronic kidney disease ( CKD) had no relation with the 30-day mortality (P=0.068), but is associated with AKI stage, anemia,hypoalbuminemia,heart failure, cancer, and multiple organ dysfunction syndrome (MODS).Renal replacement therapy was the protective factor for AonC patients . Conclusion The incidence and mortality of AKI were quite high in the AKI elderly patients .Complication of CKD is not related with their short-term prognosis .
出处
《中华老年多器官疾病杂志》
2016年第12期923-926,共4页
Chinese Journal of Multiple Organ Diseases in the Elderly
基金
首都医科大学基础-临床科研合作基金-李桓英基金(14JL-L02)~~